These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35921360)

  • 1. Prolactin at moderately increased levels confers a neuroprotective effect in non-secreting pituitary macroadenomas.
    Paul DA; Rodrigue A; Contento N; Haber S; Hoang R; Rahmani R; Hirad A; Shafiq I; Williams Z; Vates GE
    PLoS One; 2022; 17(8):e0271690. PubMed ID: 35921360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the retinal nerve fibre layer and ganglion cell complex thickness in pituitary macroadenomas without optic chiasmal compression.
    Cennamo G; Auriemma RS; Cardone D; Grasso LF; Velotti N; Simeoli C; Di Somma C; Pivonello R; Colao A; de Crecchio G
    Eye (Lond); 2015 Jun; 29(6):797-802. PubMed ID: 25853400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels.
    Greenman Y; Tordjman K; Stern N
    Clin Endocrinol (Oxf); 1998 May; 48(5):547-53. PubMed ID: 9666865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide.
    Colao A; Ferone D; Lastoria S; Cerbone G; Di Sarno A; Di Somma C; Lucci R; Lombardi G
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):437-45. PubMed ID: 10762286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary prolactin-secreting tumor formation: recent developments.
    Xu RK; Wu XM; Di AK; Xu JN; Pang CS; Pang SF
    Biol Signals Recept; 2000; 9(1):1-20. PubMed ID: 10686432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A predictive algorithm for evaluating elevated serum prolactin in patients with a sellar mass.
    Cheng JS; Salinas R; Molinaro A; Chang EF; Kunwar S; Blevins L; Aghi MK
    J Clin Neurosci; 2015 Jan; 22(1):155-60. PubMed ID: 25481269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
    Barrow DL; Tindall GT; Kovacs K; Thorner MO; Horvath E; Hoffman JC
    J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging measurements of pituitary stalk compression and deviation in patients with nonprolactin-secreting intrasellar and parasellar tumors: lack of correlation with serum prolactin levels.
    Smith MV; Laws ER
    Neurosurgery; 1994 May; 34(5):834-9; discussion 839. PubMed ID: 8052379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calmodulin content in human prolactin-secreting pituitary adenoma: an inverse relationship to serum prolactin levels.
    Bridges AJ; Ho AK
    Neurosci Lett; 1988 Jul; 90(1-2):224-8. PubMed ID: 3412646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unusual case of Cushing's syndrome due to bihormonal ACTH-prolactin secreting pituitary macroadenoma with rapid response to cabergoline.
    Kunasegaran S; Croxson MS; Holdaway I; Murphy R
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28784879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time Course of Resolution of Hyperprolactinemia After Transsphenoidal Surgery Among Patients Presenting with Pituitary Stalk Compression.
    Zaidi HA; Cote DJ; Castlen JP; Burke WT; Liu YH; Smith TR; Laws ER
    World Neurosurg; 2017 Jan; 97():2-7. PubMed ID: 27671881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of retinal nerve fibre layer thickness with quantitative magnetic resonance imaging data of the optic chiasm in pituitary adenoma patients.
    Glebauskiene B; Liutkeviciene R; Zlatkute E; Kriauciuniene L; Zaliuniene D
    J Clin Neurosci; 2018 Apr; 50():1-6. PubMed ID: 29398198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand.
    de Herder WW; Reijs AE; Kwekkeboom DJ; Hofland LJ; Nobels FR; Oei HY; Krenning EP; Lamberts SW
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):755-67. PubMed ID: 9039343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of a long-acting injectable form of bromocriptine in patients with prolactin and growth hormone secreting macroadenomas.
    Tsagarakis S; Tsiganou E; Tzavara I; Nikolou H; Thalassinos N
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):593-9. PubMed ID: 7634499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of extensive spherical amyloid deposits in a prolactin-secreting pituitary macroadenoma: a radiologic-pathologic correlation.
    Levine SN; Ishaq S; Nanda A; Wilson JD; Gonzalez-Toledo E
    Ann Diagn Pathol; 2013 Aug; 17(4):361-6. PubMed ID: 23602507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated double pituitary adenomas: A silent corticotroph adenoma and a microprolactinoma.
    Eytan S; Kim KY; Bleich D; Raghuwanshi M; Eloy JA; Liu JK
    J Clin Neurosci; 2015 Oct; 22(10):1676-8. PubMed ID: 26067545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin-secreting macroadenomas in adolescents. Response to bromocriptine therapy.
    Tyson D; Reggiardo D; Sklar C; David R
    Am J Dis Child; 1993 Oct; 147(10):1057-61. PubMed ID: 8213676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroretinal evaluation using optical coherence tomography in patients affected by pituitary tumors.
    Altun Y; Karadag AS; Yucetas SC; Saglam S; Tak AZA; Cag I; Ehi Y
    Ann Ital Chir; 2017; 88():7-14. PubMed ID: 28447589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation and outcome of pituitary adenomas in teenagers.
    Cannavò S; Venturino M; Curtò L; De Menis E; D'Arrigo C; Tita P; Billeci D; Trimarchi F
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):519-27. PubMed ID: 12641637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Speed of response to dopaminergic agents in prolactinomas.
    Hage C; Salvatori R
    Endocrine; 2022 Mar; 75(3):883-888. PubMed ID: 34846682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.